BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18282258)

  • 1. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edrophonium for the antagonism of neuromuscular blockade in dogs.
    Clutton RE
    Vet Rec; 1994 Jun; 134(26):674-8. PubMed ID: 7941276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
    Abdulatif M; El-Sanabary M
    Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine-edrophonium mixture: a dose-response study.
    Naguib M; Gomaa M; Absood GH
    Anesth Analg; 1988 Jul; 67(7):650-5. PubMed ID: 3382038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular and cardiovascular effects of atracurium administered to healthy horses anesthetized with halothane.
    Hildebrand SV; Arpin D
    Am J Vet Res; 1988 Jul; 49(7):1066-71. PubMed ID: 3421529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium priming for antagonism of atracurium neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Can J Anaesth; 1990 Mar; 37(2):197-201. PubMed ID: 2311149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of pancuronium neuromuscular blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
    Hildebrand SV; Howitt GA
    Am J Vet Res; 1984 Nov; 45(11):2276-80. PubMed ID: 6524720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium.
    Hennart D; d'Hollander A; Plasman C; De Jonckheere M
    Anesthesiology; 1986 Mar; 64(3):384-7. PubMed ID: 3754099
    [No Abstract]   [Full Text] [Related]  

  • 15. Autonomic and cardiovascular effects of neuromuscular blockade antagonism in the dog.
    Clutton RE; Boyd C; Flora R; Payne J; McGrath CJ
    Vet Surg; 1992; 21(1):68-75. PubMed ID: 1580060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus does not affect the neuromuscular blocking action of atracurium in dogs.
    Leece EA; Clark L
    Vet Anaesth Analg; 2017 Jul; 44(4):697-702. PubMed ID: 28863931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review.
    Brinch JHW; Söderström CM; Gätke MR; Madsen MV
    Acta Anaesthesiol Scand; 2019 May; 63(5):564-575. PubMed ID: 30548256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the muscarinic effects of edrophonium with atropine or glycopyrrolate. A comparative study.
    Mirakhur RK
    Br J Anaesth; 1985 Dec; 57(12):1213-6. PubMed ID: 4084429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.